https://pipelinereview.com/topas-therapeutics-initiates-phase-2a-clinical-trial-for-tpm502-in-celiac-disease-appoints-chief-business-officer-and-chief-operating-officer/
Topas Therapeutics Initiates Phase 2a Clinical Trial for TPM502 in Celiac Disease; Appoints Chief Business Officer and Chief Operating Officer